01Electromed reported Q1 2026 EPS of $0.32, beating consensus estimates of $0.26 by $0.06 or 23.1%.
02Revenue of $18.7M missed the estimate of $18.9M, indicating mixed operational results.
03The stock trades at $25.87 with a market capitalization of $247.2M as of the earnings announcement.
04Electromed has beaten EPS estimates in four consecutive quarters, ranging from 21.9% to 40.0% surprise margins.
Earnings Results
Electromed (AMEX:ELMD) reported quarterly earnings results on November 10, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $0.32, beating the consensus estimate of $0.26 by $0.06 per share. Revenue came in at $18.7M, missing the estimate of $18.9M.
Company Overview
Electromed's stock moved following the earnings release. The stock currently trades at $25.87 with a market capitalization of $247.2M.
Electromed's earnings outperformance reflects execution that exceeded Wall Street's expectations. Earnings beats can lead to upward estimate revisions from analysts, which often correlate with sustained stock price appreciation over the following weeks as models are updated.
The 23% beat relative to consensus estimates is a notable deviation. Earnings surprises of this magnitude often trigger analyst revisions and can influence institutional positioning in the weeks following the report.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking Electromed should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.